Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Wall Street
Price Targets
MIRM Price Targets Summary
Mirum Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for MIRM is 49.89 USD with a low forecast of 33.33 USD and a high forecast of 75.6 USD.
MIRM Last Price Targets
Mirum Pharmaceuticals Inc
The latest public price target was made on Apr 16, 2024 by Dae Gon Ha from Stifel Nicolaus , who expects MIRM stock to rise by 86% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Dae Gon Ha
Stifel Nicolaus
|
48
USD
Upside 86% |
2 weeks ago
Apr 16, 2024
|
Mirum Pharmaceuticals initiated with a Buy at Stifel
TheFly
|
Ed Arce
H.C. Wainwright
|
58
USD
Upside 124% |
1 month ago
Mar 14, 2024
|
Mirum Pharamceuticals (MIRM) PT Raised to $58 at H.C. Wainwright
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MIRM's stock price target?
Price Target
49.89
USD
According to Wall Street analysts, the average 1-year price target for MIRM is 49.89 USD with a low forecast of 33.33 USD and a high forecast of 75.6 USD.
What is Mirum Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
43%
The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 43%.